Welcome to
On Feet Nation
Posted by Josephine on August 16, 2024 at 10:12pm 0 Comments 0 Likes
Posted by Amy on August 16, 2024 at 10:12pm 0 Comments 0 Likes
Market Analysis and Insights:- Global Deep vein thrombosis (DVT) Treatment Market
Global Deep vein thrombosis (DVT) Treatment Market By Treatment Type (Medication, Devices and Surgery), Drugs (Anticoagulants, Heparin, Others), Devices (Neurovascular Embolectomy Devices, Inferior VenaCava Filters (IVCF) and Others), Route of Administration (Oral, Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Deep Vein Thrombosis (DVT) Treatment Market
Global Deep vein thrombosis (DVT) treatment market is growing at a growing CAGR of 8.5% in the forecast period of 2019-2026. Increasing research and development expenses and high demand of novel therapies are some factors fueling the market growth
Market Definition: Global Deep Vein Thrombosis (DVT) Treatment Market
Deep Vein Thrombosis (DVT) is the formation of blood clots (also known as thrombosis) in a deep vein in the body. DVT is predominantly occurs in the legs but can occur in the pelvic aareas and arms. It can lead to partial or completed blockage of circulation which eventually causes some serious medical problems.
According to the statistics published in the Indiana Vein Specialists, an estimated annual prevalence of deep vein thrombosis is up to 2 million in the United States. Growing cases of cardiovascular disorders and increases prevalence of this condition are the key factors for growth of the market.
Get More Insight About the Global Deep vein thrombosis (DVT) Treatment Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...
Market Drivers
• Increase prevalence of Deep Vein Thrombosis (DVT) worldwide is drive the growth of the market
• Growing burden of cardiovascular and trauma cases is act as drivers for market growth
• Rising improvement in health insurance coverage and availability of emergency medical services is accelerating the market growth
• Huge financial support to the researchers for developing novel intervention is enhancing the market growth
Market Restraints
• The inaccessibility and unaffordability of the effective treatment is hampering the market growth
• Lack of trained personnel and stringent safety regulations is hampering the market growth
• Rise in cases of product recalls are expect to cause a shortfall in the market
Know More About this Report @ https://www.databridgemarketresearch.com/reports/global-deep-vein-t...
Segmentation: Global Deep Vein Thrombosis (DVT) Treatment Market
By Treatment Type
• Medication
• Devices
• Surgery
By Drugs
• Anticoagulants
o Rivaroxaban
o Apixaban
o Others
• Heparin
o Heparin sodium
o Dalteparin sodium
o Others
• Others
By Devices
• Neurovascular Embolectomy Devices
• Inferior VenaCava Filters (IVCF)
• Others
By Route of Administration
• Oral
• Injectable
By End Users
• Hospitals
• Homecare
• Specialty Clinics
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• South America
o Brazil
o Rest of South America
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Turkey
o Belgium
o Netherlands
o Switzerland
o Rest of Europe
• Asia-Pacific
o Japan
o China
o South Korea
o India
o Australia
o Singapore
o Thailand
o Malaysia
o Indonesia
o Philippines
o Rest of Asia Pacific
• Middle East & Africa
o South Africa
o Rest of Middle East & Africa
Key Developments in the Market:
In Jan 2018, Baxter received the FDA approval for Bivalirudin, direct thrombin inhibitor for the treatment of patients undergoing percutaneous coronary intervention and deep vein thrombosis. A introduction of convenient frozen premixed solution of bivalirudin promote efficiency treatment for patients with this devastated condition.
In November 2017, DAIICHI SANKYO COMPANY, LIMITED launched Lixiana (doxaban tosilate hydrate), an oral anticoagulants for the treatment of recurrence prevention of venous thromboembolism, deep vein thrombosis and pulmonary thromboembolism in the Japan. The launch of Lixiana will significantly change treatment landscape for patients with deep vein thrombosis throughout the Japan.
Competitive Analysis:
Global deep vein thrombosis (DVT) treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global deep vein thrombosis (DVT) treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
Few of the major competitors currently working in the global deep vein thrombosis (DVT) treatment market are Aspen Holdings, Novartis AG, Mylan N.V., Momenta Pharmaceuticals, Inc, Hikma Pharmaceuticals PLC, Laboratorios Farmaceuticos Rovi, S.A., GL Pharma, Cobapharma, Boehringer Ingelheim GmbH, Glenmark Pharmaceuticals Inc., Bristol-Myers Squibb Company, Portola Pharmaceuticals, Inc. Daiichi Sankyo Company, Limited, Johnson & Johnson Services, Inc., Bayer AG, Bausch Health, Vasudha Pharma, Tianyu Pharmaceutical Co., Ltd., Neuland Laboratories Ltd, Mitsubishi Tanabe Pharma Corporation and others.
Research Methodology: Global Deep Vein Thrombosis (DVT) Treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-deep-vein...
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
• Current and future of global deep vein thrombosis (DVT) treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access Full report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/gl...
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation